Finafloxacin for the Treatment of cUTI and/or Acute Pyelonephritis
NCT01928433 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 225
Last updated 2017-06-20
Summary
The primary objective of this study is to evaluate the microbiological and clinical outcome of treatment with finafloxacin for 5 days versus finafloxacin for 10 days versus ciprofloxacin for 10 days as a reference comparator.
Finafloxacin shows increased activity in an acidic environment which is associated with indications such as uUTI and cUTI. Given the acidic pH of urine and concentration of finafloxacin excreted via the urinary tract in humans it should be proven if the finafloxacin treatments offer significant advantages over the currently available treatments for UTI.
Conditions
- Urinary Tract Infections
- Acute Pyelonephritis
Interventions
- DRUG
-
Finafloxacin 800 mg i.v. once daily
Infused over 60 mins \[i.v. pump\]) for at least 3 days.
- DRUG
-
Finafloxacin placebo i.v. once daily
Infused over 60 mins \[i.v. pump\]) for at least 3 days.
- DRUG
-
Finafloxacin 800 mg tablets once daily
Administered as four 200 mg tablets
- DRUG
-
Finafloxacin placebo tablets once daily
Administered as four tablets
- DRUG
-
Ciprofloxacin 400 mg i.v. twice daily
Infused over approximately 60 mins \[i.v. pump\]) for at least 3 days
- DRUG
-
Ciprofloxacin placebo i.v. twice daily
Infused over approximately 60 mins \[i.v. pump\]) for at least 3 days
- DRUG
-
Ciprofloxacin 500 mg oral twice daily
Administered as two 250 mg capsules.
- DRUG
-
Ciprofloxacin placebo oral twice daily
Administered as two capsules.
Sponsors & Collaborators
-
MerLion Pharmaceuticals GmbH
lead INDUSTRY
Principal Investigators
-
Florian Wagenlehner, Prof. · Germany: University Hospital Giessen and Marburg, Department of Urology
-
Michal Nowicki, Prof. · Poland: Medical University Lodz, Department of Nephrology
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-12-31
- Primary Completion
- 2014-06-30
- Completion
- 2015-10-31
Countries
- Germany
Study Locations
More Related Trials
-
Effect of Age and Gender on the PK and Tolerability of Finafloxacin
NCT01904162 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase III Study of Ciprofloxacin Plus Fluocinolone in Acute Otitis Externa (AOE)
NCT04636957 ·Status: UNKNOWN ·Phase: PHASE3
-
Sitafloxacin and Ertapenem Treatment for Acute Pyelonephritis Caused by Escherichia Coli
NCT02537847 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Plazomicin Compared With Meropenem for the Treatment of Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis (AP)
NCT02486627 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of CIPRO XR Versus CIPRO IR in Patients With Complicated Urinary Tract Infections
NCT00668122 ·Status: COMPLETED ·Phase: PHASE3
-
Urinary Bactericidal Activity of 4 Doses of Levofloxacin Against Fluoroquinolone-Resistant E. Coli
NCT00376376 ·Status: COMPLETED ·Phase: NA
-
IV or IV/PO Omadacycline vs. IV/PO Levofloxacin for the Treatment of Acute Pyelonephritis
NCT03757234 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin in Subjects With Community-acquired Pneumonia
NCT00717561 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Plazomicin Compared With Levofloxacin for the Treatment of Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP)
NCT01096849 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Floxin Otic Solution in the Treatment of Acute Otitis Media in Children
NCT00781521 ·Status: COMPLETED ·Phase: PHASE3
-
Amoxicillin-clavulanate Alone or in Combination With Ciprofloxacin in Low-Risk Febrile Neutropenic Adult Patients: A Prospective, Double-blind, Randomized, Non-Inferiority Multicenter, Phase III Clinical Trial.
NCT04698057 ·Status: WITHDRAWN ·Phase: PHASE3
-
Phase II Study of Oral Nafithromycin in CABP
NCT02903836 ·Status: COMPLETED ·Phase: PHASE2
-
Short Therapy for Febrile UTI in Childhood
NCT04400110 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial of the Treatment of Acute Sinusitis With Standard-dose Versus High-dose Amoxicillin/Clavulanate
NCT02340000 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment of Subjects With Acute Bacterial Sinusitis
NCT00645073 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety and Effectiveness of Levofloxacin Compared With Ciprofloxacin in Patients With Chronic Bacterial Prostatitis
NCT00236808 ·Status: COMPLETED ·Phase: PHASE3
-
To Compare Ofloxacin With Azitromycin for Pelvic Inflammatory Disease (PID) Treatment
NCT01241110 ·Status: COMPLETED ·Phase: PHASE4
-
Moxifloxacin Versus Ofloxacin Plus Metronidazole in Uncomplicated Pelvic Inflammatory Disease: Multicenter Randomized Controlled Trials
NCT01799356 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination Therapy vs. Oseltamivir Alone for Hospitalised Paediatric Influenza Patients
NCT04315194 ·Status: COMPLETED
-
Clinical Study on the Early Bactericidal Activity of Sitafloxacin Against Mycobacterium Abscessus Disease
NCT06809413 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
A Trial of HRS-8427 in the Treatment of Adults With Complicated Urinary Tract Infection, Including Acute Pyelonephritis
NCT06569056 ·Status: RECRUITING ·Phase: PHASE3
-
Safety and Efficacy Study of Oral Fosfomycin Versus Oral Levofloxacin to Treat Complicated Urinary Syndromes (FOCUS)
NCT03697993 ·Status: TERMINATED ·Phase: PHASE4
-
A Trial to Assess the Efficacy and Safety of Morinidazole in Women With Pelvic Inflammatory Disease
NCT03391440 ·Status: UNKNOWN ·Phase: PHASE4
-
Uncomplicated Pelvic Inflammatory Disease. Treatment With Moxifloxacin.
NCT00683865 ·Status: COMPLETED ·Phase: PHASE3
-
Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection
NCT01723059 ·Status: UNKNOWN ·Phase: NA